Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. - Wikidata - wikimedia - TriplyDB

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.

http://www.wikidata.org/entity/Q46801779

about

Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease Neuroprotection by spice-derived nutraceuticals: you are what you eat!Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview Oxidative Stress in Neurodegenerative Diseases Polyphenols and the human brain: plant “secondary metabolite” ecologic roles and endogenous signaling functions drive benefits Mitochondrial dysfunction: different routes to Alzheimer's disease therapy Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies Recent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative Diseases Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?Targeting neuroinflammation in Alzheimer's disease Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms A chemical analog of curcumin as an improved inhibitor of amyloid Abeta oligomerization Curcumin enhances neurogenesis and cognition in aged rats: implications for transcriptional interactions related to growth and synaptic plasticity Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease.A new chiral pyrrolyl α-nitronyl nitroxide radical attenuates β-amyloid deposition and rescues memory deficits in a mouse model of Alzheimer disease Adenosine triphosphate concentrations are higher in the brain of APOE3- compared to APOE4-targeted replacement mice and can be modulated by curcumin Essential turmeric oils enhance anti-inflammatory efficacy of curcumin in dextran sulfate sodium-induced colitis New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Nutraceuticals in cognitive impairment and Alzheimer's disease.Why pleiotropic interventions are needed for Alzheimer's disease.An update on the diagnosis and management of dementing conditions Midlife predictors of Alzheimer's disease.Curcumin, inflammation, ageing and age-related diseases.Epigenetic changes induced by curcumin and other natural compounds.Nutrition and prevention of Alzheimer's dementia.Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.Curcumin reduces amyloid fibrillation of prion protein and decreases reactive oxidative stress Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease.Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases Neuroprotective effects of curcumin on endothelin-1 mediated cell death in hippocampal neurons.Neuroprotective strategies involving ROS in Alzheimer disease.Inhalable curcumin: offering the potential for translation to imaging and treatment of Alzheimer's disease Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature Advanced drug delivery systems of curcumin for cancer chemoprevention A systematic review on natural medicines for the prevention and treatment of Alzheimer's disease with meta-analyses of intervention effect of ginkgo.Rescuing apoptotic neurons in Alzheimer's disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial.Neuroprotection and sensorimotor functional improvement by curcumin after intracerebral hemorrhage in mice Curcumin Ingestion Inhibits Mastocytosis and Suppresses Intestinal Anaphylaxis in a Murine Model of Food Allergy.

P2860

Q24203739-7BC777DE-E5B1-4771-BB84-F2179BB1269E Q24635358-D16B709D-95F8-4BDC-AB1E-83A0E997CE69 Q26750581-EFBAB3D6-0DB4-4879-B886-EE75E797117E Q26801239-F5DD526C-6253-4A11-872E-7C8E069ED2E6 Q26992098-71C14BF5-8230-4CB8-8926-ED7917E39651 Q27009475-B6F492C1-8F6C-4939-B3DD-0A217638146D Q27012755-9C1A452D-D404-404B-8199-A441ABC34761 Q28069509-5D8CC765-F8A6-451D-9E9A-9455EA1080A2 Q28071699-4656C018-54D6-4D9E-9B2F-4EA0CD21A5DE Q28078474-EC609561-7530-4E51-AFF1-956A8269F10B Q28259424-96F830D1-4F1B-48F4-BD50-3D05C4108CE3 Q28481562-47935E73-6456-4940-A991-273B4725DBBA Q28732050-E7F4BE62-01D3-4821-B807-2ECC1D1A83EB Q30426968-FFD7C724-5458-4754-B6CC-D293B35DE6F6 Q30538829-C56A9BAE-C6CD-45C9-8008-BAB035388B45 Q33632890-410564B9-914F-4307-9261-C47640CE15F9 Q33678034-FAD083DD-99E7-454B-9844-D8B32C6C6756 Q33783000-F4B2ABA4-3E00-452B-BFAA-D22B7ABBBC6E Q33791503-FF0B8675-9489-40EF-BA9E-192DD9677B6A Q33876128-8C9ABB9A-C734-49AD-8AB9-37BD5F254E00 Q33896147-8B593532-A665-4A5D-BC1F-880A8069B7D2 Q33956934-55964C80-9112-4900-81F3-16EA10EEB631 Q34102379-A6141D60-DC4E-4467-9E40-21DCFC63E1C4 Q34180255-3D97BBD0-86FB-4154-A7D7-752786DF7264 Q34369234-425DBDE3-A0DA-4333-A2EE-E60C2364F03D Q34441815-4FD2DA84-61AD-4246-9454-2DC0F99E7091 Q34533479-1B07A7C7-6D92-48F0-8B9C-DFD0656758B1 Q34590604-C98D2FF8-1CC3-4077-9096-F30BC6E84DA0 Q34594807-6F75A4E8-E15B-474D-961C-A135CC5FB048 Q34674727-8D1AF072-6B6B-4936-8674-F764A1419CE6 Q34757939-59D504ED-206C-472A-9CE7-C77588F0982D Q34978440-4B646A2E-17A1-4142-87AF-5B6F3732F758 Q34994270-28935C4D-E59F-40D8-82B4-08501E4ACDFC Q35127516-7CFDD0A6-7F8A-487F-9880-4A7AECE61C85 Q35150975-14BAB31C-B575-4CFE-9B9A-92F3CCFF19A3 Q35175561-EC4BA5A4-FAE2-4714-982C-C2444FFEE099 Q35298265-7BD97F91-63D8-4A14-B904-8D3D4A751A82 Q35358778-654FB9BD-33AE-4088-B565-05CD2C1E6087 Q35606190-23845497-2483-48E5-8C1C-077DBBC21FF9 Q35683228-F35ADED8-94DC-41E7-8B98-4A57F8492B5B

P2860

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.

http://www.wikidata.org/entity/Q46801779

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Six-month randomized, placebo- ...... tients with Alzheimer disease.

@en

Six-month randomized, placebo- ...... tients with Alzheimer disease.

@nl

type

label

Six-month randomized, placebo- ...... tients with Alzheimer disease.

@en

Six-month randomized, placebo- ...... tients with Alzheimer disease.

@nl

prefLabel

Six-month randomized, placebo- ...... tients with Alzheimer disease.

@en

Six-month randomized, placebo- ...... tients with Alzheimer disease.

@nl

P1433

Q46801779-6328B753-9A10-4650-9D0F-A4CC9B5C7DC4

P1476

Q46801779-3206E4E5-62D3-4A8E-82AE-677264E74628

P2093

Q46801779-020FE8E6-0581-4222-98D5-42FFFF9AC25B

Q46801779-04E3EA7B-CC9F-4240-9637-CD998A90BE61

Q46801779-07E99DAC-2486-42EA-8878-C5A890C8F425

Q46801779-08A82456-7091-4762-8BBB-9E990504EE31

Q46801779-0CEB10F6-F5C3-4982-9EAC-0CA8D37385E6

Q46801779-16D078B9-F9A3-44E9-A5BB-85134DD8DCA2

Q46801779-1D699BAF-385C-488E-A1F2-C9633A69F7E7

Q46801779-2FFAC19C-5D09-441C-B433-4C7E071F4AFA

Q46801779-44AF47FB-06E9-479B-B3CB-955A6ACB4BB2

Q46801779-54C4E7B1-BD36-4559-B492-B4D6AB514DB7

P304

Q46801779-39DE96F9-A4E1-40DC-9AED-BC70C1B145D9

P31

Q46801779-242A9D37-8762-4B1E-B9E2-4F74DAF3A66B

P356

Q46801779-99BFADB7-DC49-49A1-A924-E7CF3D512A20

P407

Q46801779-AB930423-296C-4AFD-A276-32539A55F4A2

P433

Q46801779-F4A942A5-1845-42CF-A7C8-8E07E5D72D9B

P478

Q46801779-8ACF8817-15AB-4FA2-8679-FF08F97D2956

P50

Q46801779-45495C9D-BB90-4830-A7F5-1B812B3C96BD

Q46801779-B16AE011-C58E-485F-BC9D-1B8C832DB77D

Q46801779-E6F73524-AAC4-460A-AD1A-2252BC653B35

P577

Q46801779-563683FB-5C8F-4462-A1D2-E5FE5200B4F6

P5875

Q46801779-5A80BCAD-D71E-43BE-9D4F-0982D298631F

P698

Q46801779-D5A058BF-73C5-42E5-8258-71713139B27E

P921

Q46801779-61780B81-19B5-44DA-B7A9-85D683FF7496

Q46801779-CD160A22-3DBA-456C-BED9-A211EC4B1A6F

Q46801779-e96265ac-58c6-4966-8a4b-b7394b1d6268

P356

JCP.0B013E318160862C

P1433

Journal of Clinical Psychopharmacology

P1476

Six-month randomized, placebo- ...... tients with Alzheimer disease.

@en

P2093

Adrian Wong

http://www.w3.org/2001/XMLSchema#string

Carmen Yuet Shim Fong

http://www.w3.org/2001/XMLSchema#string

Caroline Yau Lin Lai

http://www.w3.org/2001/XMLSchema#string

Chelsia Ng

http://www.w3.org/2001/XMLSchema#string

Christopher Wai Kei Lam

http://www.w3.org/2001/XMLSchema#string

Chung Shun Ho

http://www.w3.org/2001/XMLSchema#string

Elsie Hui

http://www.w3.org/2001/XMLSchema#string

Hazel Mok

http://www.w3.org/2001/XMLSchema#string

Helen Fung Kum Chiu

http://www.w3.org/2001/XMLSchema#string

Iris Hiu Shuen Chan

http://www.w3.org/2001/XMLSchema#string

P304

110-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/JCP.0B013E318160862C

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Benny Chung-Ying Zee

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5647975

http://www.w3.org/2001/XMLSchema#string

P698

18204357

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease